Cancer research
Avelumab First-Line Maintenance Shows Consistent Clinical Benefits in Urothelial Cancer Study
A new research study has shed light on the effectiveness of avelumab first-line maintenance in patients with advanced urothelial carcinoma (UC). The study, led by researchers at the University of Washington, has provided insights into the real-world outcomes of this treatment approach, which has been approved for patients who are